Diamonds in the Rough
Cross-referencing fundamental value against technical exhaustion to isolate beaten-down XLV constituents that screen cheap and oversold. The bottom-right quadrant — high earnings yield, low RSI — is the prime hunting ground, especially where money flow (MFI) shows quiet accumulation despite the falling price.
Educational screen, not investment advice. “Diamond” classification is a mechanical valuation-vs-RSI split around the cohort median earnings yield and an RSI of 50.
Alpha Quadrant — Valuation × Technical Exhaustion
X = earnings yield (cheaper right) · Y = RSI 14 (more oversold lower) · bubble = market cap · color = money flow.
Diamond Candidates
Ranked by a composite of earnings yield, ROIC, oversold RSI, recent weakness, and improving money flow.
| # | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | DVA | DaVita Inc. | 57.7 | 7.46% | 0.40 | 42 | -4.83% | 47 | grey |
| 2 | CVS | CVS HEALTH CORPORATION | 51.7 | 7.72% | -- | 51 | -2.65% | 67 | distress |
| 3 | BMY | Bristol-Myers Squibb Co. | 51.6 | 7.14% | 0.66 | 56 | +4.55% | 67 | safe |
| 4 | ABBV | ABBVIE INC. | 50.9 | 3.55% | 65.88 | 63 | +2.34% | 61 | safe |
| 5 | GEHC | GE HealthCare Technologies Inc. Common Stock | 50.0 | 7.11% | 0.54 | 68 | +18.94% | 64 | safe |
| 6 | ILMN | Illumina Inc | 48.8 | 3.02% | 0.37 | 35 | -22.54% | 44 | safe |
| 7 | ZTS | ZOETIS INC. | 48.7 | 8.12% | 0.46 | 59 | +9.28% | 63 | safe |
| 8 | PFE | Pfizer Inc. | 47.3 | 6.05% | 0.42 | 45 | -2.30% | 46 | safe |
| 9 | UHS | Universal Health Services, Inc. Class B | 44.8 | 11.90% | 0.24 | 59 | +2.35% | 60 | grey |
| 10 | CNC | Centene Corporation | 42.6 | 7.37% | 0.08 | 55 | +1.22% | 59 | safe |
| 11 | HCA | HCA Healthcare, Inc. | 41.5 | 7.86% | 0.42 | 61 | +5.06% | 50 | grey |
| 12 | ELV | Elevance Health, Inc. | 40.8 | 6.79% | 0.26 | 55 | +0.16% | 53 | safe |
| 13 | CI | The Cigna Group | 40.2 | 8.40% | -- | 51 | +1.19% | 48 | distress |
| 14 | PODD | Insulet Corporation | 39.6 | 5.37% | 0.27 | 56 | +11.70% | 68 | safe |
| 15 | IDXX | Idexx Laboratories Inc | 39.0 | 2.68% | 1.56 | 72 | +30.82% | 66 | safe |
Short-Squeeze Watch
Constituents with the highest composite squeeze score — heavy short interest meeting price support.
| # | |||||||
|---|---|---|---|---|---|---|---|
| 1 | HSIC | Henry Schein Inc | 52.4 | 9.84% | 8.30 | -0.65% | high |
| 2 | RMD | ResMed Inc. | 48.4 | 7.51% | 7.05 | +0.58% | elevated |
| 3 | INCY | Incyte Genomics Inc | 45.1 | 6.30% | 5.58 | +7.33% | elevated |
| 4 | DVA | DaVita Inc. | 43.2 | 8.25% | 5.14 | -4.83% | elevated |
| 5 | PODD | Insulet Corporation | 40.7 | 7.71% | 4.25 | +11.70% | elevated |
| 6 | UHS | Universal Health Services, Inc. Class B | 40.6 | 6.17% | 3.58 | +2.35% | elevated |
| 7 | SOLV | Solventum Corporation | 37.7 | 3.48% | 4.60 | +0.30% | elevated |
| 8 | ALGN | Align Technology Inc | 37.7 | 5.94% | 3.95 | +16.95% | elevated |
| 9 | MRNA | Moderna, Inc. Common Stock | 37.3 | 9.13% | 1.76 | -0.94% | elevated |
| 10 | CAH | Cardinal Health, Inc. | 36.9 | 3.28% | 4.19 | +11.55% | elevated |
| 11 | GEHC | GE HealthCare Technologies Inc. Common Stock | 35.7 | 4.05% | 4.87 | +18.94% | elevated |
| 12 | ILMN | Illumina Inc | 35.7 | 5.62% | 3.67 | -22.54% | elevated |
Market cap, valuation, and short-interest metrics are joined to the latest XLV holdings snapshot; each ticker links to its full quote and analysis page.